病理検査機器市場：機器別、用途別、エンドユーザー別-2025～2030年の世界予測

病理検査機器市場は、2023年に74億6,000万米ドルと評価され、2024年には79億4,000万米ドルに達すると予測され、CAGR 7.11％で成長し、2030年には120億7,000万米ドルに達すると予測されています。

調査対象範囲には、臨床と研究ラボに不可欠な、細胞レベルでの疾患の分析、診断、研究に使用されるツールやデバイスが幅広く含まれます。この市場を牽引しているのは、正確な診断の必要性、個別化医療の進展、医療支出の増加です。病理検査機器には病理組織検査機器、臨床顕微鏡、免疫組織化学製品などが含まれ、病理医が病気の病因を特定するために体組織や体液を検査するのに広く使用されています。主要な最終用途セグメントには、病院、診断ラボ、学術機関、製薬会社などがあります。主要成長要因としては、デジタル病理学やAIベースの分析などの技術的進歩、病理学的評価を必要とする慢性疾患の有病率の上昇が挙げられます。さらに、これらの機器にロボット工学と自動化が統合されることで、効率と診断精度の向上が期待され、大きな市場機会がもたらされます。

病理検査機器市場における最新のビジネス機会は、診断スピードと精度を向上させるデジタル病理学ソリューションとAI対応ワークフローの導入にあります。また、テレパソロジーやクラウドコンピューティングの採用が増加していることも、潜在的な成長の道を示しています。しかし、市場開拓は、高い機器コスト、熟練した専門家の限られた利用可能性、製品開発と採用を制限する可能性のある厳しい規制基準などの課題に直面しています。さらに、小規模のクリニックや研究所では、先進的病理学的技術に必要な多額の投資に苦戦する可能性があります。イノベーションを活用するために、企業は小規模な環境に適した、費用対効果が高く、コンパクトで使いやすい機器の開発に注力すべきです。AIアルゴリズムとリアルタイムデータ共有技術のさらなる調査により、現在の市場の限界に対処し、予測診断のための知見を提供することができます。

病理検査機器市場は、継続的な技術進歩と進化する医療要件に起因するダイナミックな性質が特徴です。成長を目指す企業は、技術共同開発のためのパートナーシップ、未充足の診断ニーズを持つ新興国市場の開拓、より良い市場ポジショニングのためのデータ分析の活用を優先すべきです。こうした努力は、競合の強化と長期的な市場持続性につながる可能性があります。

市場力学：急速に進化する病理検査機器市場における主要市場洞察の解明

病理検査機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患の流行と診断情報のニーズの高まり
  • 診断と病理検査室の拡大
  • 病理診断サービス向上への政府の取り組みとデジタル病理ソリューションの台頭
• 市場抑制要因
  • 機器関連のエラーと潜在的な精度の問題
• 市場機会
  • 病理検査機器の性能向上のための進歩
  • 創薬における病理検査ツールの採用と個別化診断に対する患者の嗜好性
• 市場課題
  • 病理検査機器の取り扱いの難しさと病理検査ツールの安全性の問題

ポーターのファイブフォース：病理検査機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：病理検査機器市場における外部からの影響の把握

外部マクロ環境要因は、病理検査機器市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：病理検査機器市場における競合情勢の把握

病理検査機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：病理検査機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、病理検査機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の罹患率が上昇し、診断情報の必要性が高まっている
    • 診断と病理学研究所の拡大
    • 病理学サービスの改善に向けた政府の取り組みとデジタル病理学ソリューションの台頭
  • 抑制要因
    • 機器関連のエラーと潜在的な精度の問題
  • 機会
    • 病理検査機器のパフォーマンスを向上させるための進歩
    • 病理学ツールの創薬への導入と個別化診断に対する患者の好み
  • 課題
    • 病理検査機器の取り扱いの難しさや病理学ツールの安全性の問題
• 市場セグメンテーション分析
  • 機器：主要メーカーによる血液学機器の機能向上に向けた取り組み
  • 用途：分子病理学におけるイノベーションを支援する研究開発イニシアチブ
  • エンドユーザー：病気の検出に対する重要な需要に応えるために、世界中で診断ラボを拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 病理検査機器市場：機器別

• イントロダクション
• 遠心分離機
• サイトメーター
• デジタル病理学ソリューション
• デジタル病理学システム
• 血液学機器
• 免疫組織化学（IHC）機器
• インキュベーター
• ミクロトーム
• 染色機
• 組織処理機器

第7章 病理検査機器市場：用途別

• イントロダクション
• 解剖病理学
• 臨床病理学
• 分子病理学

第8章 病理検査機器市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 診断ラボ
• 病院

第9章 南北アメリカの病理検査機器市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の病理検査機器市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの病理検査機器市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Metrion Biosciences、研究所拡大支援のため350万ポンド（470万米ドル）の資金調達を完了
  • PerkinElmer、ライフサイエンス企業Covarisを買収
  • Versant DiagnosticsがDahl-Chase Pathology and Diagnostic Groupsと提携
  • 3DHISTECHとEprediaが病理学イノベーションインキュベーターを開設し、がん診断の進歩を加速
  • AbbottのAlinity hシリーズ血液学システムがFDAの承認を取得
  • Discovery Life Sciencesがフルスペクトル臨床フローサイトメトリーで臨床検査を強化
  • NikonがECLIPSE Ui正立デジタル顕微鏡を発表
  • Siemens Healthineers、次世代血液分析機器を発売
  • Siemens Healthineers、EuroMedLabで次世代血液分析機器を発表
  • Leica Biosystems、BOND-PRIME高度染色ソリューションを発売
  • Agilent、USCAPでエンドツーエンドのデジタル病理学ワークフローソリューションを発表2023年
  • HamamatsuとSiemens Healthineers、全スライドスキャナの臨床市場への販売を発表
  • ClarapathがCrosscopeを買収し、組織処理ロボットとAI搭載デジタル病理学を組み合わせて未来のラボを構築
  • Siemens Healthineers、ソーズに実験機器研究開発センターを開設

企業一覧

• Mikroscan Technologies, Inc.
• Bio-Genex Laboratories
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Hamilton Company
• Hologic, Inc.
• Amos Scientific Pty. Ltd.
• Olympus Corporation
• Abbott Laboratories
• Becton, Dickinson and Company
• Shimadzu Corporation
• Bio SB Inc.
• Hamamatsu Photonics K.K.
• Nihon Kohden Corporation
• RWD Life Science Co., Ltd.
• QIAGEN N.V.
• VOGEL MedTec GmbH
• Diatron Group by STRATEC SE
• Merck KGaA
• Agilent Technologies, Inc.
• Horiba Corporation
• PerkinElmer Inc.
• Danaher Corporation
• Jinan Olabo Technology Co., Ltd.
• PHC Holdings Corporation
• Sysmex Corporation
• Waters Corporation
• Sakura Finetek Japan Co., Ltd.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche AG
• Siemens Healthineers AG
• Illumina Inc.
• Carl Zeiss AG
• BRAND GMBH+CO KG
• Thermo Fisher Scientific Inc.
• Diapath S.p.A.

LIST OF FIGURES

• FIGURE 1. PATHOLOGY INSTRUMENTS MARKET RESEARCH PROCESS
• FIGURE 2. PATHOLOGY INSTRUMENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PATHOLOGY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PATHOLOGY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PATHOLOGY INSTRUMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PATHOLOGY INSTRUMENTS MARKET DYNAMICS
• TABLE 7. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIGITAL PATHOLOGY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIGITAL PATHOLOGY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY HEMATOLOGY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC) INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY STAINING MACHINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 57. INDIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. ITALY PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 109. ITALY PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. ITALY PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. POLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 121. POLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. POLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. QATAR PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 124. QATAR PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. QATAR PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM PATHOLOGY INSTRUMENTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM PATHOLOGY INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. PATHOLOGY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 154. PATHOLOGY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Pathology Instruments Market was valued at USD 7.46 billion in 2023, expected to reach USD 7.94 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 12.07 billion by 2030.

The scope of pathology instruments encompasses a wide range of tools and devices used to analyze, diagnose, and research diseases at the cellular level, essential for both clinical and research laboratories. This market is driven by the necessity for precise diagnosis, advancing personalized medicine, and increasing healthcare expenditures. Pathology instruments include histopathology devices, clinical microscopes, immunohistochemistry products, and more, used extensively by pathologists to examine body tissues and fluids to identify disease etiology. Essential end-use sectors include hospitals, diagnostic labs, academic institutes, and pharmaceutical companies. Key growth factors include technological advancements, such as digital pathology and AI-based analytics, and the rising prevalence of chronic diseases requiring pathology assessment. Furthermore, the integration of robotics and automation within these instruments highlights significant market opportunities, promising enhancements in efficiency and diagnostic accuracy.

The latest opportunities in the pathology instruments market lie in embracing digital pathology solutions and AI-enabled workflows, which improve diagnostic speed and accuracy. The increasing adoption of telepathology and cloud computing also presents potential growth avenues. However, market growth faces challenges, such as high instrument costs, limited availability of skilled professionals, and stringent regulatory standards that could restrict product development and adoption. Additionally, smaller clinics and labs might struggle with the substantial investments required for advanced pathologic technologies. To tap into innovation, companies should focus on developing cost-effective, compact, and user-friendly instruments suitable for smaller settings. Further research into AI algorithms and real-time data sharing technology could address current market limitations, providing insights for predictive diagnostics.

The pathology instruments market is characterized by its dynamic nature, owing to continuous technological progress and evolving healthcare requirements. Firms aiming for growth should prioritize partnerships for technological co-development, exploring emerging markets with unmet diagnostic needs, and leveraging data analytics for better market positioning. These efforts could result in enhanced competitive standing and long-term market sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pathology Instruments Market

The Pathology Instruments Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic diseases worldwide and the need for diagnostic information
  • Expansion of diagnostics and pathology laboratories
  • Government initiatives to improve pathology services and the rise of digital pathology solutions
• Market Restraints
  • Instrument-related errors and potential accuracy issues
• Market Opportunities
  • Advancements to improve the performance of pathology instruments
  • Adoption of pathology tools in drug discovery and patient preference for personalized diagnosis
• Market Challenges
  • Difficulties in handling pathology instruments and safety issues of pathology tools

Porter's Five Forces: A Strategic Tool for Navigating the Pathology Instruments Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pathology Instruments Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pathology Instruments Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pathology Instruments Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pathology Instruments Market

A detailed market share analysis in the Pathology Instruments Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pathology Instruments Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pathology Instruments Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Mikroscan Technologies, Inc., Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., Fujifilm Holdings Corporation, Hamilton Company, Hologic, Inc., Amos Scientific Pty. Ltd., Olympus Corporation, Abbott Laboratories, Becton, Dickinson and Company, Shimadzu Corporation, Bio SB Inc., Hamamatsu Photonics K.K., Nihon Kohden Corporation, RWD Life Science Co., Ltd., QIAGEN N.V., VOGEL MedTec GmbH, Diatron Group by STRATEC SE, Merck KGaA, Agilent Technologies, Inc., Horiba Corporation, PerkinElmer Inc., Danaher Corporation, Jinan Olabo Technology Co., Ltd., PHC Holdings Corporation, Sysmex Corporation, Waters Corporation, Sakura Finetek Japan Co., Ltd., Koninklijke Philips N.V., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Illumina Inc., Carl Zeiss AG, BRAND GMBH + CO KG, Thermo Fisher Scientific Inc., and Diapath S.p.A..

Market Segmentation & Coverage

This research report categorizes the Pathology Instruments Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Instruments, market is studied across Centrifuges, Cytometers, Digital Pathology Solutions, Digital Pathology Systems, Hematology Instruments, Immunohistochemistry (IHC) Instruments, Incubators, Microtomes, Staining Machines, and Tissue Processors.
• Based on Application, market is studied across Anatomic Pathology, Clinical Pathology, and Molecular Pathology.
• Based on End-User, market is studied across Academic & Research Institutes, Diagnostic Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases worldwide and the need for diagnostic information
    • 5.1.1.2. Expansion of diagnostics and pathology laboratories
    • 5.1.1.3. Government initiatives to improve pathology services and the rise of digital pathology solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Instrument-related errors and potential accuracy issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements to improve the performance of pathology instruments
    • 5.1.3.2. Adoption of pathology tools in drug discovery and patient preference for personalized diagnosis
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulties in handling pathology instruments and safety issues of pathology tools
• 5.2. Market Segmentation Analysis
  • 5.2.1. Instruments: Efforts by key manufacturers to advance the capabilities of hematology instruments
  • 5.2.2. Application: R&D initiatives to support the innovations in molecular pathology
  • 5.2.3. End-User: Expansion of diagnostic laboratories across the world to serve the critical demand for disease detection
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pathology Instruments Market, by Instruments

• 6.1. Introduction
• 6.2. Centrifuges
• 6.3. Cytometers
• 6.4. Digital Pathology Solutions
• 6.5. Digital Pathology Systems
• 6.6. Hematology Instruments
• 6.7. Immunohistochemistry (IHC) Instruments
• 6.8. Incubators
• 6.9. Microtomes
• 6.10. Staining Machines
• 6.11. Tissue Processors

7. Pathology Instruments Market, by Application

• 7.1. Introduction
• 7.2. Anatomic Pathology
• 7.3. Clinical Pathology
• 7.4. Molecular Pathology

8. Pathology Instruments Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals

9. Americas Pathology Instruments Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pathology Instruments Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pathology Instruments Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Metrion Biosciences Closes GBP 3.5 Million (USD 4.7 Million) Financing to Support Lab Expansion
  • 12.3.2. PerkinElmer Acquires Life Sciences Firm Covaris
  • 12.3.3. Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups
  • 12.3.4. 3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics
  • 12.3.5. Abbott's Alinity h-series Haematology System Receives FDA Approval
  • 12.3.6. Discovery Life Sciences Boosts Clinical Trials with Full-Spectrum Clinical Flow Cytometry
  • 12.3.7. Nikon introduces the ECLIPSE Ui Upright Digital Microscope
  • 12.3.8. Siemens Healthineers Launches Next-gen Hematology Analyzers
  • 12.3.9. Siemens Healthineers to Unveil Next-gen Hematology Analyzers at EuroMedLab 2023
  • 12.3.10. Leica Biosystems Launches BOND-PRIME Advanced Staining Solution
  • 12.3.11. Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
  • 12.3.12. Hamamatsu and Siemens Healthineers Announce the Distribution of the Whole Slide Scanners to Clinical Markets
  • 12.3.13. Clarapath Acquires Crosscope and Combines Tissue Processing Robotics with AI-Powered Digital Pathology for Building the Lab of the Future
  • 12.3.14. Siemens Healthineers Launch Laboratory Equipment R&D Centre In Swords

Companies Mentioned

• 1. Mikroscan Technologies, Inc.
• 2. Bio-Genex Laboratories
• 3. Bio-Rad Laboratories, Inc.
• 4. Fujifilm Holdings Corporation
• 5. Hamilton Company
• 6. Hologic, Inc.
• 7. Amos Scientific Pty. Ltd.
• 8. Olympus Corporation
• 9. Abbott Laboratories
• 10. Becton, Dickinson and Company
• 11. Shimadzu Corporation
• 12. Bio SB Inc.
• 13. Hamamatsu Photonics K.K.
• 14. Nihon Kohden Corporation
• 15. RWD Life Science Co., Ltd.
• 16. QIAGEN N.V.
• 17. VOGEL MedTec GmbH
• 18. Diatron Group by STRATEC SE
• 19. Merck KGaA
• 20. Agilent Technologies, Inc.
• 21. Horiba Corporation
• 22. PerkinElmer Inc.
• 23. Danaher Corporation
• 24. Jinan Olabo Technology Co., Ltd.
• 25. PHC Holdings Corporation
• 26. Sysmex Corporation
• 27. Waters Corporation
• 28. Sakura Finetek Japan Co., Ltd.
• 29. Koninklijke Philips N.V.
• 30. F. Hoffmann-La Roche AG
• 31. Siemens Healthineers AG
• 32. Illumina Inc.
• 33. Carl Zeiss AG
• 34. BRAND GMBH + CO KG
• 35. Thermo Fisher Scientific Inc.
• 36. Diapath S.p.A.